Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports—a complication analysis of more than 1000 TIVAP implantations

[1]  Lara A. Kahale,et al.  Anticoagulation for people with cancer and central venous catheters. , 2018, The Cochrane database of systematic reviews.

[2]  G. Villa,et al.  Infection of totally implantable venous access devices: A review of the literature , 2018, The journal of vascular access.

[3]  M. Mello,et al.  Risk factors for central line–associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study , 2017, Pediatric blood & cancer.

[4]  P. Solal-Céligny,et al.  Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer , 2017, Supportive Care in Cancer.

[5]  M. Freire,et al.  Risk factors for infectious and noninfectious complications of totally implantable venous catheters in cancer patients. , 2016, Journal of vascular surgery. Venous and lymphatic disorders.

[6]  C. Geng,et al.  Totally implantable venous access port systems and associated complications: A single-institution retrospective analysis of 2,996 breast cancer patients. , 2016, Molecular and clinical oncology.

[7]  B. Pereira,et al.  Outcome of totally implantable venous-access port-related infections. , 2016, Medecine et maladies infectieuses.

[8]  T. Soyer,et al.  Evaluation of the removal reasons of totally implantable venous devices in children: a retrospective study. , 2016, The Turkish journal of pediatrics.

[9]  F. Cardoso,et al.  Central venous access in oncology: ESMO Clinical Practice Guidelines. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  T. Seo,et al.  Incidence and Risk Factors of Infectious Complications Related to Implantable Venous-Access Ports , 2014, Korean journal of radiology.

[11]  D. Radice,et al.  Cost Effectiveness of Different Central Venous Approaches for Port Placement and Use in Adult Oncology Patients: Evidence From a Randomized Three-Arm Trial , 2014, Annals of Surgical Oncology.

[12]  H. Wolf,et al.  Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  D. Lebeaux,et al.  Management of infections related to totally implantable venous-access ports: challenges and perspectives. , 2014, The Lancet. Infectious diseases.

[14]  A. Shiraishi,et al.  A retrospective statistical analysis of the late complications associated with central venous port placements , 2014, Japanese Journal of Radiology.

[15]  M. Prins,et al.  International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer , 2013, Journal of thrombosis and haemostasis : JTH.

[16]  S. Ahn,et al.  Ultrasound and Fluoroscopy-Guided Placement of Central Venous Ports via Internal Jugular Vein: Retrospective Analysis of 1254 Port Implantations at a Single Center , 2012, Korean journal of radiology.

[17]  U. Teichgräber,et al.  Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems , 2011, European Radiology.

[18]  K. Rufibach,et al.  Randomized clinical trial comparing venous cutdown with the Seldinger technique for placement of implantable venous access ports , 2009, The British journal of surgery.

[19]  D. Farge,et al.  2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  J. Macfie,et al.  ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). , 2009, Clinical nutrition.

[21]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  S. Breitenstein,et al.  Infectious Port Complications Are More Frequent in Younger Patients with Hematologic Malignancies than in Solid Tumor Patients , 2008, Oncology.

[23]  S. Loibl,et al.  Management of venous port systems in oncology: a review of current evidence. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  C. Seiler,et al.  Reasons for Explantation of Totally Implantable Access Ports: A Multivariate Analysis of 385 Consecutive Patients , 2008, Annals of Surgical Oncology.

[25]  R. Ramphal.  Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  A. Zerati,et al.  Totally implantable venous catheters for chemotherapy: experience in 500 patients , 2004, Sao Paulo medical journal = Revista paulista de medicina.

[27]  I. Di Carlo,et al.  Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. , 2001 .

[28]  H. Weiss,et al.  Central Venous Access Ports Placed by Interventional Radiologists: Experience with 125 Consecutive Patients , 2001, CardioVascular and Interventional Radiology.

[29]  S. Povoski.  A Prospective Analysis of the Cephalic Vein Cutdown Approach for Chronic Indwelling Central Venous Access in 100 Consecutive Cancer Patients , 2000, Annals of Surgical Oncology.

[30]  S. Zinner.  Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  A. Kluge,et al.  Durchleuchtungsgesteuerte Implantation subkutaner Venenports: Komplikationen und Langzeitergebnisse , 1998 .

[32]  T. Burke,et al.  Outcome of 350 implanted chest ports placed by interventional radiologists. , 1997, Journal of vascular and interventional radiology : JVIR.

[33]  D. Hovsepian,et al.  Interventional radiologic placement of chest wall ports: results and complications in 161 consecutive placements. , 1997, Journal of vascular and interventional radiology : JVIR.

[34]  J. L. Hernández,et al.  The complications of central venous access systems: a study of 218 patients. , 1993, The European journal of surgery = Acta chirurgica.

[35]  M. Mauro,et al.  Radiology-assisted placement of implantable subcutaneous infusion ports for long-term venous access. , 1992, Radiology.

[36]  F. Au.  The anatomy of the cephalic vein. , 1989, The American surgeon.

[37]  J. Edney,et al.  Insertion of Hickman catheters. A comparison of cutdown and percutaneous techniques. , 1984, The American surgeon.

[38]  J. Niederhuber,et al.  Totally implanted venous and arterial access system to replace external catheters in cancer treatment. , 1982, Surgery.